Business Development + Partnering

Overview

With approximately $225 million in annual sponsored research funding and more than 800,000 square feet of state-of-the-art laboratory space, Children's Hospital Boston is home to the world's largest and most active research enterprise at a pediatric center. Ranked #1 nationally in 2010 by US News & World Report in Heart & Heart Surgery, Neurology & Neurosurgery, Orthopedics, Kidney and Urology, and #2 in Diabetes & Endocrinology and Neonatology, and #3 in Cancer, Gastroenterology and Pulmonology—Children’s Hospital is a national leader in numerous clinical and research disciplines.

Children's Hospital Boston's world-renowned research and clinical excellence make us a partner of choice for projects at all stages of research and development. From early stage basic science research through translational development of validated concepts to licensing of patented innovations and clinical investigation for regulatory approval of new products—Children's Hospital is committed to bringing cutting edge technology and treatments to the public and patients world wide.

It is the mission of the Technology and Innovation Development Office (TIDO) to translate the laboratory and clinical research excellence of Children’s Hospital Boston into products for the public benefit.

TIDO utilizes a three pronged approach to accomplish this mission:

1. PATENTS and LICENSING GROUP
   With an annual research base of ~ $225M, Children’s Hospital researchers generate an average of 110 new invention disclosures per year. These innovations are evaluated by the Patents and Licensing Group for patentability and ultimately marketed and licensed to strong and committed commercial partners. This has generated 195 active licenses and numerous products currently on the market—generating ~$20M in gross revenue per year that fuels the research enterprise and further innovation.
2. BUSINESS DEVELOPMENT
   With approximately 200 collaborations with industry over the past five years, Children’s Hospital has become a partner of choice for companies wishing to collaborate with our nationally recognized researchers and clinicians. Business Development within TIDO enables R&D collaborations with industry partners by matching parties with complementary objectives and resources—creating partnerships at all stages of research, development, and pre-clinical and clinical investigation.
3. TECHNOLOGY DEVELOPMENT
   Children’s Hospital Boston launched a Technology Development Fund in early 2009 aimed at advancing the stage of development of promising Children’s Hospital technologies. With an external advisory board of industry leaders in pharmaceutical, biotechnology, device and diagnostic product development and a network of development partners and contract research organizations (CROs)—Children’s Hospital is investing in the discoveries and innovations of its researchers to translate them into products.